Machine learning can predict death, heart attack with 90% accuracy

AI can predict death or heart attack better than humans, according to a new study presented at the International Conference on Nuclear Cardiology and Cardiac CT (ICNC) in Lisbon.

A machine learning algorithm was able to predict heart attack or death by identifying patterns correlating variables to both outcomes with more than 90% accuracy. By repeatedly analyzing 85 variables in 950 patients with known six-year outcomes, the algorithm learn how imaging data interacts and outpaced humans in predicting death or heart attack.

Current methods to make treatment decisions are based on the use of risk scores, but doctors aren’t able to take into account as many variables as machine learning, resulting in less accuracy in these scores.

“Our study shows that very high dimensional patterns are more useful than single dimensional patterns to predict outcomes in individuals and for that we need machine learning,” study author Luis Eduardo Juarez-Orozco, MD, PhD, of the Turku PET Centre, Finland, said in a statement.

The study looked at 950 patients with chest pains who underwent usual protocol by the Turku PET Centre in Finland to search for coronary artery disease. Fifty-eight pieces of data on presence of coronary plaque, vessel narrowing and calcification were found in a coronary computed tomography and angiography (CCTA). Patients with scans that suggested the disease underwent further testing, including a positron emission tomography, producing 17 blood flow variables, and researchers pulled out another 10 variables, such as sex, age, smoking and diabetes, from medical records.

Using just the 10 variables from the medical records produced modest results in predictive performance, with an area under the curve (AUC) of 0.65. When the PET scan data was added, AUC improved to 0.69, with the predictive performance increasing significantly with CCTA added to an AUC of 0.82 and more than 90% accuracy.

Over an average six-year follow-up with the patients, there were 24 heart attacks and 49 deaths.

“Doctors already collect a lot of information about patients – for example those with chest pain,” Juarez-Orozco said. “We found that machine learning can integrate these data and accurately predict individual risk. This should allow us to personalize treatment and ultimately lead to better outcomes for patients.”

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."
 

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Trimed Popup
Trimed Popup